News
Strategic collaboration agreement reached between Biocytogen and Berkeley Lights for second Beacon Optofluidic system
September 14, 2020, Beijing | Beijing Biocytogen Co., Ltd. (“Biocytogen”) reached a collaboration with Berkeley Lights Inc. (“Berkeley Lights”) on the introduction of the second Beacon Optofluidic system. The system will be used in the development of antibody therapeutics to…
Keep ReadingPress Releases
RenMab™ Mouse Platform Drives SARS CoV-2 Neutralizing Antibody Cocktail Therapy Towards Clinical Trials in Biocytogen and Eucure Biopharma Partnership
[MA, USA and Beijing, China – August] The COVID-19 pandemic has been an inescapable, lethal, and overwhelming aspect of daily human life, threatening health and safety on a global scale. Biocytogen is excited to announce a breakthrough in scientific research…
Keep ReadingNews
RenMab™ and RenLite® Models Featured in GEN Magazine
In the August issue of Genetic Engineering & Biotechnology News, Biocytogen’s RenMab™ (fully human antibody mouse) and RenLite® (common light chain) models are introduced in the article, as well as a case study using RenMab™ to generate timely monoclonal antibody treatment…
Keep ReadingPress Releases
Biocytogen Closes $79M Series D Funding
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way…
Keep ReadingBlog
Understanding the Uses of the Rosa26 Knock-In Mouse
The Rosa26 locus in the mouse genome is a “safe harbor” which allows researchers to express genes of interest. Different gene targeting technologies (embryonic stem cells; CRISPR) are used to make specific DNA insertions at the Rosa26 locus. The rationale…
Keep ReadingNews
Biocytogen’s Renmab Mouse is featured on Fiercebiotech
Biocytogen’s RenMab™ Mouse is featured on Fiercebiotech.com today. Read the full article here. RenMab™ Mouse highlights: Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology Variable regions of heavy chain and k light chain are replaced by human counterparts in situ Constant region…
Keep ReadingNews
RenMab™ Mouse Featured in GEN Magazine
Biocytogen’s RenMab™ Mouse is featured in the Nov. Issue of Genetic Engineering & Biotechnology News (GEN). Read the full article here. RenMab™ Mouse highlights: Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology Variable regions of heavy chain and k light…
Keep Reading